Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia.

Boyle JA, Cunningham J, O'Dea K, Dunbar T, Norman RJ.

Med J Aust. 2012 Jan 16;196(1):62-6.

PMID:
22256938
2.

Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.

Boyle JA, Cunningham J, Norman RJ, Dunbar T, O'Dea K.

Intern Med J. 2015 Dec;45(12):1247-54. doi: 10.1111/imj.12910.

PMID:
26387977
3.

Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital.

Wongwananuruk T, Indhavivadhana S, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, Angsuwathana S, Dangrat C.

J Med Assoc Thai. 2010 Apr;93(4):399-405.

PMID:
20462080
4.

Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.

Indhavivadhana S, Wongwananuruk T, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, Popijan M.

J Med Assoc Thai. 2010 Jun;93(6):653-60.

PMID:
20572369
5.

[Epidemiological study of clinical characteristics of Chinese Han ethnic women with polycystic ovary syndrome].

Zhao JL, Chen ZJ, Zhao LX, Geng L, Wang S, Gao SS, Zhang P, Liu S, Zhou FR.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jun;41(6):375-9. Chinese.

PMID:
16831357
6.

Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus.

Wijeyaratne CN, Waduge R, Arandara D, Arasalingam A, Sivasuriam A, Dodampahala SH, Balen AH.

BJOG. 2006 Oct;113(10):1182-7.

7.

[Exploration of the classification of polycystic ovarian syndrome].

Lin JF, Li X, Zhu MW.

Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Chinese.

PMID:
17199924
8.
9.

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

Kumar A, Woods KS, Bartolucci AA, Azziz R.

Clin Endocrinol (Oxf). 2005 Jun;62(6):644-9.

PMID:
15943823
10.
11.
12.

The impact of ethnicity on the presentation of polycystic ovarian syndrome.

Williamson K, Gunn AJ, Johnson N, Milsom SR.

Aust N Z J Obstet Gynaecol. 2001 May;41(2):202-6.

PMID:
11453273
13.

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.

Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG.

Hum Reprod. 2008 Oct;23(10):2352-8. doi: 10.1093/humrep/den263. Epub 2008 Jul 16.

PMID:
18635531
14.

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.

Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB.

Hum Reprod. 2008 Jun;23(6):1431-8. doi: 10.1093/humrep/den090. Epub 2008 Mar 21.

PMID:
18359783
15.
16.

Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women.

Davis SR, Knight S, White V, Claridge C, Davis BJ, Bell R.

Gynecol Endocrinol. 2002 Dec;16(6):443-6.

PMID:
12626030
18.

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.

Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.

BJOG. 2006 Oct;113(10):1210-7.

19.

Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.

Amini M, Horri N, Farmani M, Haghighi S, Sattari G, Pornaghshband Z, Aminorroaya A.

Gynecol Endocrinol. 2008 Aug;24(8):423-7. doi: 10.1080/09513590802306143.

PMID:
18850378
20.

[Elevated blood pressure in women with polycystic ovary syndrome: prevalence and associated risk factors].

Azevedo MF, Costa EC, Oliveira AI, Silva IB, Marinho JC, Rodrigues JA, Azevedo GD.

Rev Bras Ginecol Obstet. 2011 Jan;33(1):31-6. Portuguese.

Supplemental Content

Support Center